Literature DB >> 26908025

PDEStrIAn: A Phosphodiesterase Structure and Ligand Interaction Annotated Database As a Tool for Structure-Based Drug Design.

Chimed Jansen1, Albert J Kooistra1, Georgi K Kanev1, Rob Leurs1, Iwan J P de Esch1, Chris de Graaf1.   

Abstract

A systematic analysis is presented of the 220 phosphodiesterase (PDE) catalytic domain crystal structures present in the Protein Data Bank (PDB) with a focus on PDE-ligand interactions. The consistent structural alignment of 57 PDE ligand binding site residues enables the systematic analysis of PDE-ligand interaction fingerprints (IFPs), the identification of subtype-specific PDE-ligand interaction features, and the classification of ligands according to their binding modes. We illustrate how systematic mining of this phosphodiesterase structure and ligand interaction annotated (PDEStrIAn) database provides new insights into how conserved and selective PDE interaction hot spots can accommodate the large diversity of chemical scaffolds in PDE ligands. A substructure analysis of the cocrystallized PDE ligands in combination with those in the ChEMBL database provides a toolbox for scaffold hopping and ligand design. These analyses lead to an improved understanding of the structural requirements of PDE binding that will be useful in future drug discovery studies.

Mesh:

Substances:

Year:  2016        PMID: 26908025     DOI: 10.1021/acs.jmedchem.5b01813

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  11 in total

1.  Exploring the Activity Profile of TbrPDEB1 and hPDE4 Inhibitors Using Free Energy Perturbation.

Authors:  Lorena Zara; Francesca Moraca; Jacqueline E Van Muijlwijk-Koezen; Barbara Zarzycka; Robert Abel; Iwan J P de Esch
Journal:  ACS Med Chem Lett       Date:  2022-05-23       Impact factor: 4.632

2.  Targeting a Subpocket in Trypanosoma brucei Phosphodiesterase B1 (TbrPDEB1) Enables the Structure-Based Discovery of Selective Inhibitors with Trypanocidal Activity.

Authors:  Antoni R Blaazer; Abhimanyu K Singh; Erik de Heuvel; Ewald Edink; Kristina M Orrling; Johan J N Veerman; Toine van den Bergh; Chimed Jansen; Erin Balasubramaniam; Wouter J Mooij; Hans Custers; Maarten Sijm; Daniel N A Tagoe; Titilola D Kalejaiye; Jane C Munday; Hermann Tenor; An Matheeussen; Maikel Wijtmans; Marco Siderius; Chris de Graaf; Louis Maes; Harry P de Koning; David S Bailey; Geert Jan Sterk; Iwan J P de Esch; David G Brown; Rob Leurs
Journal:  J Med Chem       Date:  2018-05-01       Impact factor: 7.446

3.  The single cyclic nucleotide-specific phosphodiesterase of the intestinal parasite Giardia lamblia represents a potential drug target.

Authors:  Stefan Kunz; Vreni Balmer; Geert Jan Sterk; Michael P Pollastri; Rob Leurs; Norbert Müller; Andrew Hemphill; Cornelia Spycher
Journal:  PLoS Negl Trop Dis       Date:  2017-09-15

4.  Surface Binding Energy Landscapes Affect Phosphodiesterase Isoform-Specific Inhibitor Selectivity.

Authors:  Qing Liu; Andreas Herrmann; Qiang Huang
Journal:  Comput Struct Biotechnol J       Date:  2018-12-28       Impact factor: 7.271

5.  PDE9 Inhibitor PF-04447943 Attenuates DSS-Induced Colitis by Suppressing Oxidative Stress, Inflammation, and Regulating T-Cell Polarization.

Authors:  Mohammad Nasiruddin Rana; Jie Lu; Enfu Xue; Jingjing Ruan; Yuting Liu; Lejun Zhang; Rana Dhar; Yajun Li; Zhengqiang Hu; Jie Zhou; Wangqian Ma; Huifang Tang
Journal:  Front Pharmacol       Date:  2021-04-08       Impact factor: 5.810

6.  Discovery of highly selective and orally available benzimidazole-based phosphodiesterase 10 inhibitors with improved solubility and pharmacokinetic properties for treatment of pulmonary arterial hypertension.

Authors:  Yuncong Yang; Sirui Zhang; Qian Zhou; Chen Zhang; Yuqi Gao; Hao Wang; Zhe Li; Deyan Wu; Yinuo Wu; Yi-You Huang; Lei Guo; Hai-Bin Luo
Journal:  Acta Pharm Sin B       Date:  2020-04-18       Impact factor: 11.413

7.  Exploring the binding mechanisms of PDE5 with chromeno[2,3-c]pyrrol-9(2H)-one by theoretical approaches.

Authors:  Xianfeng Huang; Peng Xu; Yijing Cao; Li Liu; Guoqiang Song; Lei Xu
Journal:  RSC Adv       Date:  2018-08-29       Impact factor: 4.036

8.  Function-specific virtual screening for GPCR ligands using a combined scoring method.

Authors:  Albert J Kooistra; Henry F Vischer; Daniel McNaught-Flores; Rob Leurs; Iwan J P de Esch; Chris de Graaf
Journal:  Sci Rep       Date:  2016-06-24       Impact factor: 4.379

Review 9.  Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases.

Authors:  Heng Li; Jianping Zuo; Wei Tang
Journal:  Front Pharmacol       Date:  2018-10-17       Impact factor: 5.810

10.  Development of a Fingerprint-Based Scoring Function for the Prediction of the Binding Mode of Carbonic Anhydrase II Inhibitors.

Authors:  Giulio Poli; Vibhu Jha; Adriano Martinelli; Claudiu T Supuran; Tiziano Tuccinardi
Journal:  Int J Mol Sci       Date:  2018-06-23       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.